Phill is the Business Analyst for M:M Bio where he provides commercial insight for the group. In his role, he is responsible for strategy, market & financial analytics, and competitive intelligence for Grey Wolf Therapeutics. He has a strong passion for solving real world problems using science and technology – aligning him well with Grey Wolf’s goals.
Phill has a background in consumer business and tech, working in large multinational companies in a variety of commercial sales and project management roles, as well and more recently in the Canadian tech startup ecosystem as a software developer and product manager. He has always been passionate about supporting science commercially, and worked as a founder for a company supporting scientists to gain access to emerging alternative funding sources in North America.
Originally from New Zealand, Phill has just moved to Oxford UK from Vancouver where he has been living since 2017. He is a recent MBE (Bioscience Enterprise) graduate from the University of Cambridge in 2021, with prior undergraduate studies at the Otago University in Chemistry and Business.